Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer

International Journal of Cancer

Volumn 68, Issue 3, 1996, Pages 372-377

  Endo, Kazuya ^a   Maehara, Yoshihiko ^b   Kusumoto, Tetsuya ^a   Ichiyoshi, Yuji ^b   Kuwano, Michihiko ^b   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; TETRAZOLIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029806169     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961104)68:3<372::AID-IJC16>3.0.CO;2-A     Document Type: Article

References (28)

1. ALLUM, W.H., HALLISSEY, M.T, and KELLY, K.A., Adjuvant chemotherapy in operable gastric cancer. 5-year follow-up of first British stomach cancer group trial. Lancet, 1, 571-574 (1989).
2. CARMICHAEL, J., DEGRAFF, W.G., GAZDAR, A.F., MINNA, J.D. and MITCHELL, J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47, 936-942 (1987).
3. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.G., KURZ, E.U., DUNCAN, A.M. and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Wash.), 258, 1650-1654 (1992).
4. COLE, S.P.C., CHANDA, E.R., DICKE, F.P., GERLACH, J.H. and MIRSKI, S.E., Non-P-glycoprotein-mediated multidrug resistance in a small-cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Res., 51, 3345-3352 (1991).
5. COLE, S.P.C., SPARKS, K.E., FRASER, K., LOE, D.W., GRANT. C.E., WILSON, G.M. and DEELEY, R.G., Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54, 5902-5910 (1994).
6. ENDO, K., MAEHARA, Y., ICHIYOSHI, Y., KUSUMOTO, T., SAKAGUCHI, Y., OHNO, S. and SUGIMACHI, K., Multidrug resistance-associated protein expression in clinical gastric cancer. Cancer, 77, 1681-1687 (1996).
7. FLENS, M.J., IZQUITERDO, M.A., SCHEFFER, G.L., FRITZ, J.M., MEIJER, C.J., SCHEPER, R.G. and ZAMAN, G.J., Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug resistant tumor cells by monoclonal antibodies. Cancer Res., 54, 4557-4563 (1994).
8. GOLDSTEIN, L.J., GALSKI, H., FOJO, A., WILLINGHAM, M., LAI, S-L., GAZDAR, A., PIRKER, R., GREEN, A., CRIST, W., BRODEUR, G.M., LIEBER, M., COSSMAN, J., GOTTESMAN, M.M. and PASTAN, I., Expression of a multidrug resistance gene in human cancers. J. nat. Cancer Inst., 81, 116-124 (1989).
9. GOTTESMAN, M.M., How cancer cells evade chemotherapy. Cancer Res., 53, 747-754 (1993).
10. GRANT, C.E., VALDIMARSSON, G., HIPFNER, D.R., ALMOUIST, K.C., COLE, S.P.C. and DEELEY, R.G., Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54, 357-361 (1994).
11. HINDS, M., DEISSEROTH, K., MAYES, J., ALTSCHULER, E., JANSEN, R., LEDLEY, F.D. and ZWELLING, L.A., Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II. Cancer Res., 51, 4729-4731 (1991).
12. HIPFNER, D.R., GAULDIE, S.D., DEELEY, R.G. and COLE, S.P.C., Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res., 54, 5788-5792 (1994).
13. KOHNO, K., KIKUCHI, J., SATO, S., TAKANO, H., SABURI, Y., ASOH, K. and KUWANO, M., Vincristine-resistant human cancer KB cell line and increased expression of multidrug-resistance gene. Jap. J. Cancer Res., 79, 1238-1246 (1988).
14. KRISHNAMACHARY, N. and CENTER, M.S., The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound grycoprotein. Cancer Res., 53, 3658-3661 (1993).
15. KUNIYASU, H., YASUI, W., KITADAI, Y., YOKOZAKI, H., ITO, H. and TAHARA, E., Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem. biophys. Res. Comm., 189, 227-232 (1992).
16. KUSUMOTO, H., MAEHARA, Y., YOSHIDA, M., TAKAHASHI, I., ANAI, H. and SUGIMACHI, K., Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer. Anticancer Drugs, 3, 33-38 (1992).
17. LOWE, S.W., RULEY, H.E., JACKS, T. and HOUSMAN, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967 (1993).
18. MAEHARA, Y., KOHNOE, S. and SUGIMACHI, K., Chemosensitivity test for carcinoma of digestive organs. Semin. surg. Oncol., 6, 42-47 (1990).
19. MÜLLER, M., MEIJER, C., ZAMAN, G.J., BORST, P., SCHEPER, R.J., MULDER, N.H., DE VRIES, E.G. and JANSEN, P.L., Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. nat. Acad. Sci. (Wash.), 91, 13033-13037 (1994).
20. NOONAN, K.E., BECK, C., HOLZMAYER, T.A., CHIN, J.E., WUNDER, J.S., ANDRULIS, I.L., GAZDAR, A.F., WILLMAN, C.L., GRIFFITH, B., VON HOFF, D.D. and RONINSON, I.B., Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 87, 7160-7164 (1990).
21. SAITO, A., KORENAGA, D., MAEHARA, Y., BABA, H., OKAMURA, T. and SUGIMACHI, K., In vitro succinate dehydrogenase chemosensitivity of gastric carcinoma - relationship to DNA content. Cancer Chemother. Pharmacol., 29, 185-189 (1992).
22. SAKAGUCHI, Y., ANAI, H., KOHNOE, S., EMI, Y., KUSUMOTO, T., MAEHARA, Y. and SUGIMACHI, K., Resistance to anticancer drugs of well-differentiated gastric adenocarcinoma with venous invasion. Europ. J. surg. Oncol., 18, 142-145 (1992).
23. SCHNEIDER, E., HORTON, J.K., YANG, C.-H., NAKAGAWA, M. and COWAN, K.H., Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res., 54, 152-158 (1994).
24. SUGAWARA, I., WATANABE, M., MASUNAGA, A., ITOYAMA, S. and UEDA, K., Primer-dependent amplification of mdr1 mRNA by polymerase chain reaction. Jap. J. Cancer Res., 83, 131-133 (1992).
25. TASAKI, Y., NAKAGAWA, M., OGATA, J., KIUE, A., TANIMURA, H., KUWANO, M. and NOMURA, Y., Reversal dihydropyridine of non-P-glycoprotein-mediated multidrug resistance in etoposide-resistant human prostatic cancer cell line. J. Urol., 154, 1210-1216 (1995).
26. YAMADA, Y., YOSHIDA, T., HAYASHI, K., SEKIYA, T., YOKOTA, J., HIROHASHI, S., NAKATANI, K., NAKANO, H., SUGIMURA, T. and TERADA, M., p53 gene mutation in gastric cancer metastases and gastric cancer cell lines derived from metastases. Cancer Res., 51, 5800-5805 (1991).
27. ZAMAN, G.J., FLENS, M.J., VAN LEUSDEN, M.R., DE HAAS, M., MÜLDER, H.S., LANKELMA, J., PINEDO, H.M., SCHEPER, R.J., BAAS, F., BROXTERMAN, H.J. and BORST, P., The human multidrug resistance-associated protein (MRP) is a plasma membrane drug efflux pump. Proc. nat. Acad. Sci. (Wash.), 91, 8822-8826 (1994).
28. ZAMAN, G.J., VERSANTVOOT, C.H., SMIT, J.J., EIJDEMS, E.W., DE HAAS, M., SMITH, A.J., BROXTERMAN, H.J., MULDER, N.H., DE VRIES, E.G., BAAS, F. and BORST, P., Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res., 53, 1747-1750 (1993).